Source: Virtual Congress 2020 – Management prevention



Rating:

Share or cite this content

Citations should be made in the following way:
P. Openshaw (London, United Kingdom). Immunology underpinning vaccine strategy: what is the risk of reinfection?. Virtual Congress 2020 – Management prevention

Member's Comments

No comment yet.

Related content which might interest you: Seasonal influenza vaccine effectiveness in people with asthma: A systematic review Source: International Congress 2016 – Clinical studies in asthma and immunology Year: 2016 Development of RSV vaccines: where are we? Source: International Congress 2019 – Respiratory syncytial virus infections throughout life Year: 2019 Identifying genetic susceptibility to isoniazid- induced hepatitis Source: Annual Congress 2013 –Genetics and genomics of lung disease Year: 2013 The protective effect of BCG vaccination against mycobacterium tuberculosis infection in children: A systematic review Source: International Congress 2014 – Tuberculosis: public health and primary prevention Year: 2014 Advancing global programmatic management of latent tuberculosis infection for at risk populations Source: Eur Respir J 2016; 47:1327-1330 Year: 2016 Can the influenza vaccine response be predicted in COPD patients by clinical parameters? Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 H1- and H56- subunit vaccines against TB - an overview of the clinical development Source: International Congress 2014 – Tuberculosis: public health and primary prevention Year: 2014 Clinical and epidemiological assessment of the regional program of vaccination for pneumococcal infections Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Influenza surveillance and vaccination: new developments Source: International Congress 2017 – PG17 Infectious disease challenges in community-acquired pneumonia and tuberculosis: improving your clinical practice Year: 2017 Prevention of latent TB reactivation in rheumatology patients prior to anti-TNF therapy: Evaluation of a risk stratification strategy in a low prevalence area Source: International Congress 2015 – Screening strategies in TB Year: 2015 Influenza A/H1N1v infection in Belgian children with and without underlying risk factor Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors Year: 2010 Age and impact of vaccine on seasonal H1N1p severe infection Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab Year: 2016 COVID-19 vaccines: immunology, regulation and clinical management Source: Eur Respir Monogr 2021; 94: 244-260 Year: 2021 Known and emerging risk factors for asthma development: is prevention possible? Source: International Congress 2015 – Asthma: emerging risk factors and current management of the patient Year: 2015